Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Effective clinical trial compliance requires strong ICH GCP E6 R2 alignment, structured risk-based monitoring GCP strategy, and disciplined trial master file TMF governance. This guide reviews GCP inspection findings, informed consent documentation controls, and evolving ICH E6 R3 update expectations.